CD91:F:F-Lyxor NYSE Arca Gold BUGS (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 22.105

Change

+0.74 (+3.44)%

Market Cap

USD 0.31B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

ETFs Containing CD91:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.96% 38% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.96% 36% F 45% F
Trailing 12 Months  
Capital Gain -6.02% 22% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.02% 21% F 39% F
Trailing 5 Years  
Capital Gain 47.29% 66% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 47.29% 66% D+ 55% F
Average Annual (5 Year Horizon)  
Capital Gain 7.09% 77% C+ 73% C
Dividend Return 7.09% 76% C+ 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.57% 11% F 42% F
Risk Adjusted Return 27.74% 58% F 62% D
Market Capitalization 0.31B 51% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.